355
142 shares, 355 points

Debates on whether children should be vaccinated have ignited as the delta variant makes children more vulnerable to COVID-19 than before. Although the Delta variant is not new, a definite decision has not been taken yet; because experts and officials agreed that it is necessary to be cautious on this issue. We do not know when official decisions will come, but statements have been made that this time may be close.

BioNTech’s co-founder Dr. Özlem Türeci had previously stated that the vaccine that can be administered to young children is no different from the current vaccine. In the new statement made by the company, the Pfizer/BioNTech vaccine It is well tolerated in children aged 5-11 years. and was noted to induce a strong immune response.

The vaccine had a positive effect on children:

The world has come a long way in vaccination efforts against the COVID-19 virus. The vast majority of adults have been vaccinated and have taken the most effective precaution they can take. However, the delta variant, the most dangerous variant of the virus that has appeared so far, has been enough to worry us all again in recent months. It has been seen that the virus, which can have fatal consequences in young people, sometimes also targets children. Of course, they are of school age and high risk of contamination was also helpful. Therefore, evaluations began to protect children from the dangerous variant.

The American pharmaceutical company Pfizer, which co-produces the COVID-19 vaccines, and the German biotechnology company BioNTech, have concluded that the vaccine is well tolerated in people aged 5-11 as a result of ongoing research. Besides not showing any adverse reactions, the vaccine induced a strong immune response in children, making them more prone to all varyandollarars, including delta. The amount of antibodies that children in this age group get with the vaccine, was the same as that of individuals aged 16-25.

Emphasizing that child COVID-19 cases have increased by 240% in the USA, Pfizer President Albert Bourla said, “Highlights the need for public health vaccination. Clinical trial results provide a strong basis for approval of our vaccine for children ages 5 to 11, and we plan to present these results to the FDA and other authorities immediately.” stated that he hopes the vaccine will be made available for children soon. Uğur Şahin, CEO of BioNTech, before the start of the winter season announced that the data obtained for school-age children was transmitted to the competent authorities.


Like it? Share with your friends!

355
142 shares, 355 points

What's Your Reaction?

hate hate
122
hate
confused confused
858
confused
fail fail
490
fail
fun fun
368
fun
geeky geeky
245
geeky
love love
1104
love
lol lol
1226
lol
omg omg
858
omg
win win
490
win
Michael Lewis

Emperor

0 Comments

Your email address will not be published. Required fields are marked *

Choose A Format
Personality quiz
Series of questions that intends to reveal something about the personality
Trivia quiz
Series of questions with right and wrong answers that intends to check knowledge
Poll
Voting to make decisions or determine opinions
Story
Formatted Text with Embeds and Visuals
List
The Classic Internet Listicles
Countdown
The Classic Internet Countdowns
Open List
Submit your own item and vote up for the best submission
Ranked List
Upvote or downvote to decide the best list item
Meme
Upload your own images to make custom memes
Video
Youtube, Vimeo or Vine Embeds
Audio
Soundcloud or Mixcloud Embeds
Image
Photo or GIF
Gif
GIF format